Next-generation sequencing, a more sensitive test than immunohistochemistry, identifies mismatch repair deficiency in endometrial and colon cancer patients. This genetic state is often missed by standard tests, impairs DNA repair and leads to cancer. Immunotherapy, a highly effective treatment for this condition, offers significant benefits, potentially curing patients even in late-stage cancer., Health News, Times Now
English (US) ·